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Evaluation of serum heat shock protein 
70 concentration in women with 
recurrent miscarriages
ABSTRACT
Background. Heat shock proteins (Hsp) were discovered over 50 years ago and are commonly called 
‘stress proteins’. Hsp proteins play an important role in a cell, in that they provide protection against cell 
stress factors and environmentally negative factors. The most conservative, and the best known, heat 
shock proteins are Hsp 70 subfamily proteins. It has been suggested that an increase of Hsp 70 in the 
blood during pregnancy has a negative impact. The aetiology of recurrent miscarriages in more than 60% 
of women remains unexplained. Therefore the aim of this study was to evaluate the usefulness of Hsp 70 
assessment in the diagnosis of recurrent miscarriages. 
Material and methods. The study group consisted of 100 women (aged 36.0 ± 4.9 years) who had ex-
perienced repeated miscarriages. The reference group consisted of 60 women (aged 36.1 ± 3.6 years), 
who had been pregnant at least twice and who had given birth by a spontaneous labour without compli-
cations. Hsp 70 was determined in the serum. 
Results. We found no significant differences in the Hsp 70 concentration between the women with recurrent 
miscarriages and the reference group. While median serum Hsp 70 was the most elevated in the women 
with the highest number of miscarriages, this difference was not significant. 
Conclusion. Based on the obtained results, it is difficult to determine whether Hsp 70 plays a causative 
role in recurrent miscarriages. However, taking into account the fact that the role of Hsp 70 in the course 
of normal and pathological pregnancy is not yet completely understood, it may be worth expanding the 
study to include a larger group of women with recurrent miscarriages. 
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Introduction
Heat shock proteins (Hsp) were discovered over 
50 years ago and are commonly called ‘stress proteins’. 
They occur both in the cells of prokaryotes and eukary-
otes organisms, and they have a dual activity which 
results from their distribution in the cell. Extracellular 
proteins are involved in the immune response, while 
intracellular proteins play a protective role [1, 2].
These proteins belong to a family of polypeptides 
with a highly conservative primary structure. Depend-
ing on the molecular weight within the heat shock pro-
teins family, several subfamilies can be distinguished, 
including macromolecular proteins (Hsp 100, 
Hsp 90), medium-molecular proteins (Hsp 70, Hsp 60, 
Hsp 40), and low-molecular weight proteins (Hsp 27, 
Hsp 10).
It is believed that Hsp 70 subfamily proteins are the 
most conservative and most thoroughly-established 
group of heat shock proteins. In the literature there are 
several reports on the involvement of the Hsp 70 pro-
tein in various disease entities, such as cardiovascular, 
cancer, acute infections, asthma, and pregnancy patho- 
 logy [3–5]. Particularly noteworthy is the role of protein 
Hsp 70 in the pathology of pregnancy. It has been sug-
gested that heat shock protein Hsp 70 may play a role 
in embryogenesis and reproduction. As is well-known, 
extracellular protein Hsp 70 has the ability to induce 
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Table 1. Characteristics of the study and reference 
groups
Parameter Study group Reference  
group
Number (N) 100 60
Age (years) 36.0 ± 4.9 36.1 ± 3.6
Karyotype 46, XX
N (%)
100 (100%) 60 (100%)
Previous pregnancies
N (%)
18 (17%) 60 (100%)
 Number of miscarriages 
3 miscarriages
 N (%) 
4 miscarriages
 N (%) 
5 miscarriages
 N (%)
88 (86%)
10 (9%)
2 (6%)
0 (0%)
0 (0%)
0 (0%)
Smoking
N (%)
22 (21%) No data
Coexistence of other diseases
N (%)
0 ( 0%) No data
Table 2. The Hsp 70 concentration in women with recurrent pregnancy loss and in the reference group
Parameter Statistical parameter Study group Reference group p
Hsp 70 protein [ng/mL] N 100 60 0.97
Me 1.57 1.73 0.97
Q1 1.21 1.24 0.97
Q3 2.25 2.06 0.97
N — number of subjects; Me — median; Q1 — first quartile; Q3 — third quartile; p — p-value
a proinflammatory (Th1) immune response. In a normal 
pregnancy, the concentration of this protein in the blood 
decreases. It is believed that an elevated level of this 
protein in the blood of a pregnant woman has a negative 
impact on the pregnancy [6–8]. The aim of this study 
was to evaluate the concentration of Hsp 70 protein in 
the serum of women with recurrent miscarriages.
Material and methods
Studies were conducted in the Department of Lab-
oratory Medicine, Collegium Medicum in Bydgoszcz, 
University of Nicolas Copernicus in Torun. The study 
group consisted of 160 women aged 24–44 years (mean 
36.1 ± 4.4 years) of whom 100  had experienced recur-
rent pregnancy loss (mean age 36.0 ± 4.9 years), who 
reported to the Genetic Clinic at the University Hospital. 
Women with recurrent miscarriages were divided in 
terms of firstly the number of miscarriages and secondly 
the incidence of early pregnancy. The coexistence of 
chronic diseases (e.g. diabetes, hypertension), meta-
bolic diseases, hormonal disorders, thrombophilic, ana-
tomical defects, infections, antiphospholipid syndrome, 
and systemic lupus erythematosus was excluded. To 
the reference group 60 non pregnant women (aged 
36.1 ± 3.6 years) were qualified, aged from 30 to 41, 
who had been pregnant at least twice and who had 
given birth by a spontaneous labour without complica-
tions. Based on the taken history data, the coexistence 
of chronic diseases prior to the study enrollment was 
excluded in these subjects (Tab.1).
All the women were informed about the study 
purpose and gave informed, written consent for it. 
Blood was collected from the women with recurrent 
miscarriages in an outpatient setting at least six weeks 
after the miscarriage. The obtained sera were stored at 
–70°C until measurement. To determine the serum con-
centration of human heat shock protein 70 HSP-70, an 
ELISA test kit from EIAab (China) was used. The minimal 
detectable concentration of Hsp 70 was 0.039 ng/mL.
Statistical analysis
Because of nonparametric distribution of Hsp 
70 protein concentration, a nonparametric U Mann-Whit-
ney test was used for statistical analysis. Statistical 
analysis of the results of the study was performed using 
Excel 2007 of the Microsoft Office® 2007 package and 
Statistica 9.1 by StatSoft, Inc. (2010).
Results
There was no significant difference in the concen-
tration of serum Hsp 70 in women with recurrent preg-
nancy loss compared to the reference group (Tab. 2). 
The impact of the number of miscarriages on Hsp 70 
protein concentration was not significant, in spite of 
the highest median Hsp 70 in women with the highest 
number of lost pregnancies (Tab. 3). Also there were 
no significant differences in concentrations of Hsp 70 in 
women with recurrent pregnancy loss but who had 
given birth at least once compared to those who had 
never given birth (Tab. 4). It is however worth noting 
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Table 3. Comparison of the Hsp 70 values in patients with recurrent pregnancy loss based on the number of 
miscarriages
Parameter Statistical measures Number of miscarriages p
3 miscarriages 4 miscarriages 5 miscarriages
Hsp 70 protein  
[ng/mL]
N 88 10 2 0.72
Me 1.57 1.28 2.47 0.72
Q1 1.25 1.19 0.85 0.72
Q3 2.17 1.82 2.66 0.72
N — number of subjects; Me — median; Q1 — first quartile; Q3 — third quartile; p — p-value
Table 4. Concentration of Hsp 70 in women with recurrent pregnancy loss who had at least once given birth and in 
those who had never given birth
Parameter Statistical measures PN0* PN1** p
Hsp70 protein
[ ng/mL]
N 82 18 0.15
Me 1.70 1.43
Q1 1.28 1.07
Q3 2.37 1.57
N — number of subjects; Me — median; Q1 — first quartile; Q3 — third quartile; p — p-value; *PN0 — women with recurrent pregnancy loss who 
had not given birth; **PN1 —  women with recurrent pregnancy loss, who had given birth at least once
that median Hsp 70 was higher in women with recurrent 
miscarriages who had never given birth.
Discussion
It is known that in a normal pregnancy the con-
centration of the Hsp 70 protein is reduced, and that it 
shows a positive correlation with gestational age and 
an inverse correlation with maternal age. This protein 
has the ability to produce extracellular pro-inflammatory 
state Th1 response-dependent, and consequently may 
lead to rejection of the foetus by the mother as semial-
lograft. It is believed that a reduction in the circulating 
levels of the Hsp 70 protein can affect the immune 
system to maintain tolerance to the foetus in a wom-
an’s body [9]. Only a few papers in the literature have 
described Hsp 70 protein levels among patients at risk 
of preterm birth and intraamnional infections [9, 10]. 
To the best of our knowledge, this is the first study 
on the Hsp 70 concentration in the serum of women with 
recurrent miscarriages. We did not observe significant 
differences in the Hsp 70 concentration between the 
group of women with recurrent miscarriages and the 
reference group. The only important finding was that 
Hsp 70 concentration in women with fewer than five 
miscarriages was significantly lower than in women 
with five or more miscarriages (Me = 1.57 ng/mL 
v. 2.47 ng/mL), although because of the small sample 
size the difference was not statistically significant.
There is no earlier data available to compare our 
results with those of others. However, it is worth men-
tioning that Hsp 70 measurements were performed 
at least six weeks after the miscarriage, which means 
after the puerperium period. If the blood sample had 
been taken immediately after a miscarriage, then the 
obtained results might have been different. This rep-
resents a certain limitation of our study. However, taking 
blood samples for diagnostic purposes from women 
with recurrent miscarriages six weeks after an incident 
is a routine medical procedure.
The obtained results provide some information. But 
in order to broaden this, it would be good to measure the 
Hsp 70 twice, immediately after a miscarriage and again 
after six weeks. Because the role of the Hsp 70 protein 
in the course of normal and pathological pregnancy is 
not yet completely understood, it seems to us necessary 
to continue such studies with a larger group of women. 
To determine whether an elevated concentration of 
Hsp 70 is preceded by failures related to pregnancy, 
prospective studies should be carried out.
Conclusion
Currently, it is difficult to determine whether the 
Hsp 70 protein plays a role in the pathogenesis of 
recurrent miscarriages.
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